Read + Share
Atallah-Yunes SA, Khurana A, Maurer M. Challenges identifying DLBCL patients with poor outcomes to upfront
chemoimmunotherapy and its impact on frontline clinical trials. Leuk Lymphoma 2024;65:430-439.
PMID: 38180317
|
 |
|
Atallah-Yunes SA, Khurana A, Maurer M. Challenges identifying DLBCL patients with poor outcomes to upfront
chemoimmunotherapy and its impact on frontline clinical trials. Leuk Lymphoma 2024;65:430-439.
PMID: 38180317
|
|
|
|